Federal award
ALNYLAM PHARMACEUTICALS, INC.
HDTRA107C0082
Contract
Obligated and Ceiling
- Obligated (net)
- $3,526,068.00
- Ceiling (potential value, not spending)
- $38,634,245.00
- Current value
- $10,856,721.00
- Gross positive obligations
- $3,616,708.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ALNYLAM PHARMACEUTICALS, INC. · GTKHWKZJSX53
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ALNYLAM PHARMACEUTICALS, INC. · GTKHWKZJSX53
- Awarding agency
- Department of War · sub-agency 9761 · office HDTRA1
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- HDTRA107C0082
- Award type code
- D
- Actions
- 5 · Feb 21, 2008 to Feb 10, 2014
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History5
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 10, 2014 | FY2014 | P00005 | M | −$90,640.00 | — |
| Feb 19, 2010 | FY2010 | P00004 | M | $0.00 | — |
| Jul 23, 2008 | FY2008 | P00003 | B | $0.00 | — |
| Jun 4, 2008 | FY2008 | P00002 | M | $0.00 | — |
| Feb 21, 2008 | FY2008 | P00001 | C | $3,616,708.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.